title: One-carbon metabolism and other biochemical correlates of cognitive impairment as visualized by principal component analysis.
abstract: In the present report, 101 ambulatory elderly patients complaining about cognitive disturbances were investigated using the Mini-Mental State Examination (MMSE). Laboratory investigations, brain imaging, and electroencephalography were performed. Twelve patients were diagnosed with subjective memory complaints (SMC), 32 with mild cognitive impairment (MCI), 43 with dementia of the Alzheimer type (DAT), and 14 with vascular dementia (VAD). Thirty-three percent of the SMC group, 31% of the MCI group, 45% of the DAT group, and 62% of the VAD group had increased serum homocysteine (s-HCY). Principal component analysis of 19 variables showed 3 significant principal components by cross-validation. The cognitive impairment in the patients (MMSE) was explained to 50%. According to the principal component analysis, the population followed two different routes to cognitive impairment: one correlated with disturbance of one-carbon metabolism (cerebrospinal fluid vitamin B12, plasma B12, plasma folate, and s-HCY) and the other correlated with more classic dementia, as marked by cerebrospinal fluid tau, vascular risk factors, atrophy on brain imaging, possession of the apolipoprotein E4 allele, and age. There was poor discrimination between DAT and VAD.
authors.affiliation: Psychiatry Section, the Institute of Clinical Neuroscience, Göteborg University, Sahlgrenska University Hospital/Mölndal, Mölndal, Sweden.
authors.forename: J
authors.initials: J
authors.lastname: Gottfries
authors.forename: K
authors.initials: K
authors.lastname: Blennow
authors.forename: M W
authors.initials: MW
authors.lastname: Lehmann
authors.forename: B
authors.initials: B
authors.lastname: Regland
authors.forename: C G
authors.initials: CG
authors.lastname: Gottfries
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000175:diagnosis* / Q000235:genetics / Q000378:metabolism*; D001057:Apolipoproteins E / Q000235:genetics; D001284:Atrophy / Q000473:pathology; D001921:Brain / Q000378:metabolism / Q000473:pathology; D003072:Cognition Disorders / Q000175:diagnosis*; D015140:Dementia, Vascular / Q000175:diagnosis* / Q000235:genetics / Q000378:metabolism*; D003937:Diagnosis, Differential; D005260:Female; D005492:Folic Acid / Q000097:blood*; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D012016:Reference Values; D012720:Severity of Illness Index; D014805:Vitamin B 12 / Q000097:blood* / Q000134:cerebrospinal fluid*; D016875:tau Proteins / Q000134:cerebrospinal fluid*
chemical_list: D001057:Apolipoproteins E; D016875:tau Proteins; D006710:Homocysteine; D005492:Folic Acid; D014805:Vitamin B 12